HomeOKUR • NASDAQ
add
Onkure Therapeutics Inc
Previous close
$4.38
Day range
$4.52 - $4.75
Year range
$1.70 - $5.10
Market cap
62.35M USD
Avg Volume
158.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.12M | -20.88% |
Net income | -13.50M | 22.58% |
Net profit margin | — | — |
Earnings per share | -0.99 | 27.74% |
EBITDA | -14.02M | 20.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.05M | -46.69% |
Total assets | 62.12M | -45.94% |
Total liabilities | 5.93M | -46.45% |
Total equity | 56.18M | — |
Shares outstanding | 13.67M | — |
Price to book | 1.07 | — |
Return on assets | -52.33% | — |
Return on capital | -57.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.50M | 22.58% |
Cash from operations | -11.51M | 50.71% |
Cash from investing | -9.00K | -100.06% |
Cash from financing | 240.00K | -99.78% |
Net change in cash | -11.28M | -110.97% |
Free cash flow | -6.52M | 26.68% |
About
Founded
2011
Headquarters
Website
Employees
45
